ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
207 hedge funds and large institutions have $3.59B invested in Intra-Cellular Therapies Inc. in 2021 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 57 increasing their positions, 67 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
15% more funds holding
Funds holding: 180 → 207 (+27)
15% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 67
Holders
207
Holding in Top 10
8
Calls
$68.2M
Puts
$31.4M
Top Buyers
| 1 | +$76.1M | |
| 2 | +$19.5M | |
| 3 | +$16.5M | |
| 4 |
Two Sigma Investments
New York
|
+$14.5M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$11.8M |
Top Sellers
| 1 | -$22.3M | |
| 2 | -$19.6M | |
| 3 | -$19.3M | |
| 4 |
Goldman Sachs
New York
|
-$18.4M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$14.5M |